» Articles » PMID: 2793840

Targeting Genes: Delivery and Persistent Expression of a Foreign Gene Driven by Mammalian Regulatory Elements in Vivo

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1989 Oct 15
PMID 2793840
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

We present evidence that a foreign gene driven by natural mammalian regulatory elements can be targeted to hepatocytes and the resultant gene expression made to persist. This was accomplished using a soluble DNA carrier system consisting of two covalently linked components: 1) a polycation, poly-L-lysine, that can bind DNA in a strong but non-damaging interaction, and 2) an asialoglycoprotein which can be targeted specifically to hepatocytes by cell surface asialoglycoprotein receptors unique to this cell type. A plasmid, palb-CAT, containing the gene for chloramphenicol acetyltransferase (CAT) driven by mouse albumin regulatory sequences was complexed to the carrier system. Intravenous injection of palb-CAT DNA in the form of a complex resulted in the presence of CAT enzyme activity in liver homogenates 24 h after injection. The targeted gene expression, however, was transient, reaching a maximum of 10 units/g liver at 24 h but was not detectable by 96 h. However, partial hepatectomy 30 min after injection resulted in persistent high levels of hepatic CAT activity (11.3 units/g) through 11 weeks post-injection. Southern analysis of livers 11 weeks after partial hepatectomy demonstrated that some of the targeted DNA had been integrated into the host genome. We conclude that a foreign gene driven by natural mammalian regulatory elements can be delivered to hepatocytes by intravenous injection in vivo using a soluble DNA carrier system. Foreign gene expression targeted in this manner can be made to persist by stimulation of hepatocyte replication.

Citing Articles

Metabolically stabilized double-stranded mRNA polyplexes.

Poliskey J, Crowley S, Ramanathan R, White C, Mathew B, Rice K Gene Ther. 2018; 25(7):473-484.

PMID: 30154525 PMC: 6404535. DOI: 10.1038/s41434-018-0038-3.


GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.

Springer A, Dowdy S Nucleic Acid Ther. 2018; 28(3):109-118.

PMID: 29792572 PMC: 5994659. DOI: 10.1089/nat.2018.0736.


Recent trends of polymer mediated liposomal gene delivery system.

Kundu S, Sharma A, Lee S, Sharma G, George Priya Doss C, Yagihara S Biomed Res Int. 2014; 2014:934605.

PMID: 25250340 PMC: 4163454. DOI: 10.1155/2014/934605.


NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.

Martinez-Fong D, Bannon M, Trudeau L, Gonzalez-Barrios J, Arango-Rodriguez M, Hernandez-Chan N Nanomedicine. 2012; 8(7):1052-69.

PMID: 22406187 PMC: 3394898. DOI: 10.1016/j.nano.2012.02.009.


shRNA and siRNA delivery to the brain.

Pardridge W Adv Drug Deliv Rev. 2007; 59(2-3):141-52.

PMID: 17434235 PMC: 3572210. DOI: 10.1016/j.addr.2007.03.008.